232 related articles for article (PubMed ID: 19002467)
41. [Influence of high- and low-osmolality contrast media on renal function in children].
Chen CY; Cao L; Chen DK; Chu M; Tu J
Zhonghua Er Ke Za Zhi; 2006 Apr; 44(4):280-4. PubMed ID: 16780650
[TBL] [Abstract][Full Text] [Related]
42. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients.
Solomon R
Kidney Int; 2005 Nov; 68(5):2256-63. PubMed ID: 16221227
[TBL] [Abstract][Full Text] [Related]
43. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment.
Becker CR; Reiser MF
Invest Radiol; 2005 Oct; 40(10):672-5. PubMed ID: 16189436
[TBL] [Abstract][Full Text] [Related]
44. Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.
Feldkamp T; Baumgart D; Elsner M; Herget-Rosenthal S; Pietruck F; Erbel R; Philipp T; Kribben A
Clin Nephrol; 2006 Nov; 66(5):322-30. PubMed ID: 17140161
[TBL] [Abstract][Full Text] [Related]
45. Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials.
Sharma SK; Kini A
Catheter Cardiovasc Interv; 2005 Jul; 65(3):386-93. PubMed ID: 15926184
[TBL] [Abstract][Full Text] [Related]
46. Incidence of contrast-induced nephropathy in patients with chronic renal insufficiency undergoing multidetector computed tomographic angiography treated with preventive measures.
El-Hajjar M; Bashir I; Khan M; Min J; Torosoff M; DeLago A
Am J Cardiol; 2008 Aug; 102(3):353-6. PubMed ID: 18638601
[TBL] [Abstract][Full Text] [Related]
47. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium.
Langner S; Stumpe S; Kirsch M; Petrik M; Hosten N
AJNR Am J Neuroradiol; 2008 Sep; 29(8):1525-9. PubMed ID: 18524974
[TBL] [Abstract][Full Text] [Related]
48. N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Staniloae CS; Doucet S; Sharma SK; Katholi RE; Mody KR; Coppola JT; Solomon R
J Interv Cardiol; 2009 Jun; 22(3):261-5. PubMed ID: 19490358
[TBL] [Abstract][Full Text] [Related]
49. Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media.
Karlsberg RP; Dohad SY; Sheng R;
J Nephrol; 2010; 23(6):658-66. PubMed ID: 20540038
[TBL] [Abstract][Full Text] [Related]
50. Contrast-induced nephropathy: controlled study by differential GFR measurement in hospitalized patients.
Erselcan T; Egilmez H; Hasbek Z; Tandogan I
Acta Radiol; 2012 Mar; 53(2):228-32. PubMed ID: 22139722
[TBL] [Abstract][Full Text] [Related]
51. Subclinical Contrast-Induced Acute Kidney Injury in Patients Undergoing Cerebral Computed Tomography.
Breglia A; Godi I; Virzì GM; Guglielmetti G; Iannucci G; De Cal M; Brocca A; Carta M; Giavarina D; Ankawi G; Passannante A; Yun X; Biolo G; Ronco C
Cardiorenal Med; 2020; 10(2):125-136. PubMed ID: 32036364
[TBL] [Abstract][Full Text] [Related]
52. Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial.
Weiland FL; Marti-Bonmati L; Lim L; Becker HC
Acta Radiol; 2014 Jul; 55(6):715-24. PubMed ID: 24060817
[TBL] [Abstract][Full Text] [Related]
53. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
[TBL] [Abstract][Full Text] [Related]
54. Comparative effect of iso-osmolar versus low-osmolar contrast media on the incidence of contrast-induced acute kidney injury in diabetic patients: a systematic review and meta-analysis.
Zhao F; Lei R; Yang SK; Luo M; Cheng W; Xiao YQ; Li XW; Guo J; Duan SB
Cancer Imaging; 2019 Jun; 19(1):38. PubMed ID: 31215488
[TBL] [Abstract][Full Text] [Related]
55. Nephrotoxic effects of iodixanol and iopromide in patients with abnormal renal function receiving N-acetylcysteine and hydration before coronary angiography and intervention: a randomized trial.
Juergens CP; Winter JP; Nguyen-Do P; Lo S; French JK; Hallani H; Fernandes C; Jepson N; Leung DY
Intern Med J; 2009 Jan; 39(1):25-31. PubMed ID: 18771430
[TBL] [Abstract][Full Text] [Related]
56. Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.
Chen Y; Hu S; Liu Y; Zhao R; Wang L; Fu G; He Q; Su X; Zheng Y; Qi X; Liu H; Wang J; Gao W; Wang M; Liu S; Zheng X; He B; Yang P; Zhou S; Gao C; Qiu C
EuroIntervention; 2012 Nov; 8(7):830-8. PubMed ID: 23045301
[TBL] [Abstract][Full Text] [Related]
57. Coronary stent evaluation with coronary computed tomographic angiography: comparison between low-osmolar, high-iodine concentration iomeprol-400 and iso-osmolar, lower-iodine concentration iodixanol-320.
Andreini D; Pontone G; Mushtaq S; Bartorelli AL; Conte E; Bertella E; Baggiano A; Annoni A; Formenti A; Ballerini G; Agostoni P; Fiorentini C; Pepi M
J Cardiovasc Comput Tomogr; 2014; 8(1):44-51. PubMed ID: 24582042
[TBL] [Abstract][Full Text] [Related]
58. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
59. Nephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysis.
Biondi-Zoccai G; Lotrionte M; Thomsen HS; Romagnoli E; D'Ascenzo F; Giordano A; Frati G
Int J Cardiol; 2014 Mar; 172(2):375-80. PubMed ID: 24502883
[TBL] [Abstract][Full Text] [Related]
60. Pain in femoral arteriography. A double-blind, randomized, clinical study comparing safety and efficacy of the iso-osmolar iodixanol 270 mgI/ml and the low-osmolar iomeprol 300 mgI/ml in 9 European centers.
Manke C; Marcus C; Page A; Puey J; Batakis O; Fog A
Acta Radiol; 2003 Nov; 44(6):590-6. PubMed ID: 14616202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
